Severe Mental Illness and Retention in Anti-Retroviral Care: A Retrospective Study

详细信息    查看全文

• 作者：John A. Joska (1)
  Ade Obayemi Jr. (2)
  Henri Cararra (3)
  Katherine Sorsdahl (1)
  
• 关键词：Severe mental illness ; HIV ; Combination anti ; retroviral treatment ; Adherence
• 刊名：AIDS and Behavior
• 出版年：2014
• 出版时间：August 2014
• 年：2014
• 卷：18
• 期：8
• 页码：1492-1500
• 全文大小：258 KB
• 参考文献：1. Wiersma D. Needs of people with severe mental illness. Acta Psychiatr Scand Suppl. 2006;429:115-. CrossRef
  2. Kagee A, Delport T. Barriers to adherence to antiretroviral treatment: the perspectives of patient advocates. J Health Psychol. 2010;15(7):1001-1. CrossRef
  3. Lund C, Kleintjes S, Kakuma R, Flisher AJ. MHaPP Research Programme Consortium. Public sector mental health systems in South Africa: inter-provincial comparisons and policy implications. Soc Psychiatry Psychiatr Epidemiol. 2010;45(3):393-04. CrossRef
  4. Dickey B, Normand S-LT, Weiss RD, Drake RE, Azeni H. Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002;53(7):861-. CrossRef
  5. Weiden P, Glazer W. Assessment and treatment selection for “revolving door-inpatients with schizophrenia. Psychiatr Q. 1997;68(4):377-2. CrossRef
  6. Lund C, Oosthuizen P, Flisher AJ, Emsley R, Stein DJ, Botha U, et al. Pathways to inpatient mental health care among people with schizophrenia spectrum disorders in South Africa. Psychiatr Serv. 2010;61(3):235-0. CrossRef
  7. Collins PY, Berkman A, Mestry K, Pillai A. HIV prevalence among men and women admitted to a South African public psychiatric hospital. AIDS Care. 2009;21(7):863-. CrossRef
  8. Senn TE, Carey MP. HIV testing among individuals with a severe mental illness: review, suggestions for research, and clinical implications. Psychol Med. 2008;39(03):355. CrossRef
  9. Goldman LS. Medical illness in patients with schizophrenia. J Clin Psychiatry. 1999;60(Suppl 21):10-.
  10. Collins PY. Challenges to HIV prevention in psychiatric settings: perceptions of South African mental health care providers. Soc Sci Med. 2006;63(4):979-0. CrossRef
  11. Klinkenberg WD, Sacks S. For the HIV AIDS treatment adherence. Mental disorders and drug abuse in persons living with HIV/AIDS. AIDS Care. 2004;16(sup1):22-2. CrossRef
  12. Kalichman SC, Simbayi LC, Kagee A, Toefy Y, Jooste S, Cain D, et al. Associations of poverty, substance use, and HIV transmission risk behaviors in three South African communities. Soc Sci Med. 2006;62(7):1641-. CrossRef
  13. Nakimuli-Mpungu E, Mutamba B, Nshemerirwe S, Kiwuwa M, Musisi S. Effect of HIV infection on time to recovery from an acute manic episode. HIV AIDS (Auckl). 2010;2:185-.
  14. Rosen S, Fox MP, Gill CJ. Patient retention in antiretroviral therapy programs in Sub-Saharan Africa: a systematic review. PLoS Med. 2007;4(10):e298. CrossRef
  15. Reid SE, Mulenga LB, Folk WR, Tambatamba BC, Chi BH. Abandonment of antiretroviral therapy: a potential barrier to scale-up in sub-Saharan Africa. S Afr Med J. 2008;98(6):448-0.
  16. Murray LK, Semrau K, McCurley E, Thea DM, Scott N, Mwiya M, et al. Barriers to acceptance and adherence of antiretroviral therapy in urban Zambian women: a qualitative study. AIDS Care. 2009;21(1):78-6. CrossRef
  17. Nakimuli-Mpungu E, Bass JK, Alexandre P, Mills EJ, Musisi S, Ram M, et al. Depression, alcohol use and adherence to antiretroviral therapy in sub-saharan Africa: a systematic review. AIDS Behav. 2012;16(8):2101-8.
  18. Nachega JB, Mutamba B, Basangwa D, Nguyen H, Dowdy DW, Mills EJ, et al. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults. Trop Med Int Health. 2013;18(1):53-. CrossRef
  19. Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers. AIDS Care. 2011;23(2):146-1. CrossRef
  20. Mall S, Sorsdahl K, Swartz L, Joska J. “I understand just a little…-Perspectives of HIV/AIDS service providers in South Africa of providing mental health care for people living with HIV/AIDS. AIDS Care. 2012;24(3):319-3. CrossRef
  21. Rabkin JG. HIV and depression: 2008 review and update. Curr HIV/AIDS Rep. 2008;5(4):163-1. CrossRef
  22. Cournos F, McKinnon K, Sullivan G. Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus. J Clin Psychiatry. 2005;66(Suppl 6):27-3.
  23. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769-9. CrossRef
  24. Moss AR, Hahn JA, Perry S, Charlebois ED, Guzman D, Clark RA, et al. Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004;39(8):1190-. CrossRef
  25. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Correlates of HIV antiretroviral adherence in persons with serious mental illness. AIDS Care. 2004;16(4):501-. CrossRef
  26. Bogart LM, Fremont AM, Young AS, Pantoja P, Chinman M, Morton S, et al. Patterns of HIV care for patients with serious mental illness. AIDS Patient Care STDS. 2006;20(3):175-2. CrossRef
  27. Wagner GJ, Kanouse DE, Koegel P, Sullivan G. Adherence to HIV antiretrovirals among persons with serious mental illness. AIDS Patient Care STDS. 2003;17(4):179-6. CrossRef
  28. Nakimuli-Mpungu E, Musisi S. Kiwuwa Mpungu S, Katabira E. Early-onset versus late-onset HIV-related secondary mania in Uganda. Psychosomatics. 2008;49(6):530-. CrossRef
  29. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, et al. Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol. 2008;65(1):65-0. CrossRef
  30. Meade CS, Sikkema KJ. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev. 2005;25(4):433-7. CrossRef
  31. Carey MP, Carey KB, Kalichman SC. Risk for human immunodeficiency virus (HIV) infection among persons with severe mental illnesses. Clin Psychol Rev. 1997;17(3):271-1. CrossRef
  32. Fremont AM, Young AS, Chinman M, Pantoja P, Morton S, Koegel P, et al. Differences in HIV care between patients with and without severe mental illness. Psychiatr Serv. 2007;58(5):681-. CrossRef
  33. Botha UA, Koen L, Joska JA, Hering LM. Oosthuizen PP. Assessing the efficacy of a modified assertive community-based treatment programme in a developing country. BMC Psychiatry. 2010;10:73. CrossRef
  34. Joska JA, Sorsdahl KR. Integrating mental health into general health care: lessons From HIV. Afr J Psychiatry (Johannesbg). 2012;15(6):420-.
  35. Kaaya S, Eustache E, Lapidos-Salaiz I, Musisi S, Psaros C, Wissow L. Grand challenges: improving HIV treatment outcomes by integrating interventions for co-morbid mental illness. PLoS Med. 2013;10(5):e1001447. CrossRef
  36. Cornell M, Technau K, Fairall L, Wood R, Moultrie H, van Cutsem G, et al. Monitoring the South African National Antiretroviral Treatment Programme, 2003-007: the IeDEA Southern Africa collaboration. S Afr Med J. 2009;99(9):653-0.
  
• 作者单位：John A. Joska (1)
  Ade Obayemi Jr. (2)
  Henri Cararra (3)
  Katherine Sorsdahl (1)
  
  1. Department of Psychiatry and Mental Health, Groote Schuur Hospital, University of Cape Town, Anzio Road, Observatory, Cape Town, 7925, South Africa
  2. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
  3. Department of Public Health & Family Medicine, University of Cape Town, Cape Town, South Africa
  
• ISSN：1573-3254

文摘

Severe mental illness (SMI) in people living with HIV (PLWH) may impact on the initiation and adherence to combination antiretroviral treatment. We conducted a cross-sectional retrospective folder review of 100 PLWH suffering from an SMI, in Cape Town, South Africa. Information pertaining to whether these patients had attended a six-month visit at the referral HIV clinic after discharge from a psychiatric hospital was obtained. Of the 100 participants, 63 did not attend a first 6-month HIV clinic follow-up. There were no significant differences between 6-month attenders and non-attenders on demographic or clinical variables. After adjustment, respondents who had been re-admitted to a psychiatric hospital more than once were more likely not to attend their follow-up visit compared to those with no re-admissions (1 re-admission: PR?=?1.52, 95?% CI 1.00-.31; 2 or more re-admissions: PR?=?1.60, 1.08-.37). PLWH who have a co-morbid SMI are an especially vulnerable group of patients. Psychosocial support and interventions such as case management may be useful.